SHELBY KERNS: Open Payments
NPI 1578258869 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 26 payments from 15 companies in 2025. Trend: 2023 $60 · 2024 $691 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 4 | $100 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $86 |
| Incyte Corporation | 4 | $76 |
| Integra LifeSciences Corporation | 2 | $74 |
| Genentech USA, Inc. | 3 | $70 |
| Kerecis Limited | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| Smith+Nephew, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $23 |
Products named: TAVALISSE, JOURNAVX, Integra, MONJUVI, Polivy, Kerecis SurgiClose, ORGOVYX, ELAHERE.
Industry payments across CT — which companies pay providers there.
